Radcliffe Capital Management’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

Radcliffe Capital Management’s Portfolio REVH Stock Details REVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-725,062	Closed	-$7.12M	–	1108
2022 Q3	$7.12M	Buy	725,062 +256	+0%	+$2.51K	0.17%	137
2022 Q2	$7.08M	Buy	724,806 +77,071	+12%	+$754K	0.16%	132
2022 Q1	$6.35M	Buy	647,735 +511,058	+374%	+$4.98M	0.14%	146
2021 Q4	$1.33M	Hold	136,677	–	–	0.03%	721
2021 Q3	$1.33M	Hold	136,677	–	–	0.04%	609
2021 Q2	$1.34M	Buy	+136,677	New	+$1.35M	0.04%	629

Radcliffe Capital Management's REVH Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 725,062 shares — an estimated $7.12M sold.

Radcliffe Capital Management first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $7.12M in Q3 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

Radcliffe Capital Management reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 725,062 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $7.12M.
Radcliffe Capital Management first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
Radcliffe Capital Management's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $7.12M in Q3 2022.
0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.